Search for other papers by Xiuzhen Hou in
Google Scholar
PubMed
Search for other papers by Junfeng Zhang in
Google Scholar
PubMed
Search for other papers by Hehong Ma in
Google Scholar
PubMed
Search for other papers by Ming Li in
Google Scholar
PubMed
Search for other papers by Pei Wang in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) is primarily resulted from insulin resistance and glucose intolerance during pregnancy, affecting 7% of pregnant women globally ( 1 , 2 ). GDM causes higher risks of diabetes, obesity and
Search for other papers by Zhiwei Zhang in
Google Scholar
PubMed
Search for other papers by Hui Zhao in
Google Scholar
PubMed
Search for other papers by Aixia Wang in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) manifests as various degrees of hyperglycemia during pregnancy. GDM has a high incidence rate and is by far one of the leading causes of neonatal and maternal mortality ( 1 ). The etiology of
Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed
Search for other papers by Liliana Fonseca in
Google Scholar
PubMed
Search for other papers by Maria Teresa Pereira in
Google Scholar
PubMed
Search for other papers by Joana Vilaverde in
Google Scholar
PubMed
Search for other papers by Clara Pinto in
Google Scholar
PubMed
Search for other papers by Fernando Pichel in
Google Scholar
PubMed
Search for other papers by Maria do Céu Almeida in
Google Scholar
PubMed
Search for other papers by Jorge Dores in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus(GDM) is defined as a subtype of hyperglycemia first detected during pregnancy and accounts for 90% of all diabetes diagnoses in pregnant women ( 1 , 2 ). This represents a worrying gestational
Search for other papers by Huguette S Brink in
Google Scholar
PubMed
Search for other papers by Aart Jan van der Lely in
Google Scholar
PubMed
Search for other papers by Joke van der Linden in
Google Scholar
PubMed
Introduction Gestational diabetes (GD) is defined as any glucose intolerance with onset or first recognition during pregnancy. GD has a prevalence of 7% worldwide, depending on the population studied and diagnostic criteria used ( 1 ). The
PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
Search for other papers by Sanna Mustaniemi in
Google Scholar
PubMed
PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
Search for other papers by Marja Vääräsmäki in
Google Scholar
PubMed
Folkhälsan Research Centre, Helsinki, Finland
Search for other papers by Johan G Eriksson in
Google Scholar
PubMed
Division of Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
Search for other papers by Mika Gissler in
Google Scholar
PubMed
Department of Obstetrics and Gynaecology, Tampere University Hospital, Tampere, Finland
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
Search for other papers by Hannele Laivuori in
Google Scholar
PubMed
PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
Search for other papers by Hilkka Ijäs in
Google Scholar
PubMed
Search for other papers by Aini Bloigu in
Google Scholar
PubMed
PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Eero Kajantie in
Google Scholar
PubMed
Search for other papers by Laure Morin-Papunen in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) and polycystic ovary syndrome (PCOS) are the most common endocrine disorders in women of reproductive age. The prevalence of GDM varies from 9% to 25% and the prevalence of PCOS varies from 5
Search for other papers by Angela Köninger in
Google Scholar
PubMed
Search for other papers by Antonella Iannaccone in
Google Scholar
PubMed
Search for other papers by Ensar Hajder in
Google Scholar
PubMed
Search for other papers by Mirjam Frank in
Google Scholar
PubMed
Search for other papers by Boerge Schmidt in
Google Scholar
PubMed
Search for other papers by Ekkehard Schleussner in
Google Scholar
PubMed
Search for other papers by Rainer Kimmig in
Google Scholar
PubMed
Search for other papers by Alexandra Gellhaus in
Google Scholar
PubMed
Search for other papers by Hans Dieplinger in
Google Scholar
PubMed
pregnancy complications like gestational diabetes mellitus (GDM) ( 11 , 12 ). IR, as determined with homeostasis model assessment (HOMA-IR) ( 13 ), when present before the beginning of a pregnancy seems to be the strongest factor associated with the
Search for other papers by Alice S Ryan in
Google Scholar
PubMed
Search for other papers by John C McLenithan in
Google Scholar
PubMed
Search for other papers by Gretchen M Zietowski in
Google Scholar
PubMed
Introduction Women with a history of gestational diabetes mellitus (GDM) are at an increased risk for the development of type 2 diabetes mellitus (T2DM) within 5 years following pregnancy (1, 2) with the reported incidence of T2DM ranging from
Search for other papers by Yusen Liu in
Google Scholar
PubMed
Search for other papers by Ruiwen Chi in
Google Scholar
PubMed
Search for other papers by Yujie Jiang in
Google Scholar
PubMed
Search for other papers by Bicheng Chen in
Google Scholar
PubMed
Search for other papers by Youli Chen in
Google Scholar
PubMed
Search for other papers by Zengrui Chen in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM), the most common medical disorder in pregnancy, is defined as glucose intolerance resulting in hyperglycemia that begins or is first diagnosed during pregnancy ( 1 ). GDM is associated with
Chronic Disease Epidemiology Laboratory Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Leishen Wang in
Google Scholar
PubMed
Search for other papers by Huikun Liu in
Google Scholar
PubMed
Search for other papers by Shuang Zhang in
Google Scholar
PubMed
Search for other papers by Junhong Leng in
Google Scholar
PubMed
Search for other papers by Weiqin Li in
Google Scholar
PubMed
Search for other papers by Tao Zhang in
Google Scholar
PubMed
Search for other papers by Nan Li in
Google Scholar
PubMed
Search for other papers by Wei Li in
Google Scholar
PubMed
Search for other papers by Andrea A Baccarelli in
Google Scholar
PubMed
Search for other papers by Lifang Hou in
Google Scholar
PubMed
Search for other papers by Gang Hu in
Google Scholar
PubMed
Introduction The worldwide rise in over-nutrition, sedentary life and obesity has resulted in a steep increase in the number of women who develop gestational diabetes mellitus (GDM) during pregnancy ( 1 ). Nearly 7% of pregnancies in the
O&G ACP, Duke-NUS Graduate Medical School, Singapore, Singapore
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
Search for other papers by Ling-Jun Li in
Google Scholar
PubMed
Search for other papers by Izzuddin M Aris in
Google Scholar
PubMed
Search for other papers by Lin Lin Su in
Google Scholar
PubMed
Department of O&G, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Search for other papers by Yap Seng Chong in
Google Scholar
PubMed
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
Search for other papers by Tien Yin Wong in
Google Scholar
PubMed
O&G ACP, Duke-NUS Graduate Medical School, Singapore, Singapore
Search for other papers by Kok Hian Tan in
Google Scholar
PubMed
Search for other papers by Jie Jin Wang in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) and hypertensive disorders of pregnancy (HDP) are two of the most commonly seen pregnancy complications that adversely affect both short-term and long-term maternal and fetal outcomes ( 1 , 2